Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 09 Jul 2024

Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway

in Renal Pharmacology

Jie Qu
Hui Pei
Xin-Ze Li
Yan Li
Jian-Ming Chen
Min Zhang
Zhong-Qiu Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414918

2,824 views
2 citations

Original Research

Published on 04 Jul 2024

De-indexed estimated glomerular filtration rates for the dosing of oral antidiabetic drugs in patients with chronic kidney disease

in Renal Pharmacology

Maxime Pluquet
Marie Metzger
Christian Jacquelinet
Christian Combe
Denis Fouque
Maurice Laville
Luc Frimat
Ziad A. Massy
Sophie Liabeuf
Solène M. Laville

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375838

1,987 views

Original Research

Published on 01 Jul 2024

Bibliometric and visual analysis of immunisation associated with acute kidney injury from 2003 to 2023

in Renal Pharmacology

Ling Chen
Jing Hu
Jianrao Lu
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388527

2,415 views
1 citation

Original Research

Published on 28 Jun 2024

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

in Renal Pharmacology

David A. Vesey
Abishek Iyer
Evan Owen
Danielle Kamato
David W. Johnson
Glenda C. Gobe
David P. Fairlie
David J. Nikolic-Paterson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382094

2,173 views
2 citations

Systematic Review

Published on 25 Jun 2024

Influence of sodium/glucose cotransporter-2 inhibitors on the incidence of acute kidney injury: a meta-analysis

in Renal Pharmacology

Qian Wang
Jianmin Yu
Weizhu Deng
Chao Liu
Jian Yang
Yaqing Li
Guangyan Cai
Xiangmei Chen
Zheyi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372421

2,186 views
2 citations

Original Research

Published on 21 Jun 2024

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system

in Renal Pharmacology

Jingyi Zhang
Yuting Guo
Chunyan Wei
Yu Yan
Huifang Shan
Bin Wu
Fengbo Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363501

2,292 views
2 citations

Original Research

Published on 19 Jun 2024

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

in Renal Pharmacology

Xiangmeng Li
Shimin Jiang
Xia Gu
Xiaojing Liu
Shunlai Shang
Jiao Zhang
Keying Pang
Wenge Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380326

2,521 views
3 citations

Original Research

Published on 12 Jun 2024

SGLT2i treatment during AKI and its association with major adverse kidney events

in Renal Pharmacology

Luz Alcantar-Vallin
Jose J. Zaragoza
Bladimir Díaz-Villavicencio
Karla Hernandez-Morales
Jahir R. Camacho-Guerrero
Miguel A. Perez-Venegas
Edgar J. Carmona-Morales
Alexa N. Oseguera-Gonzalez
Cesar Murguia-Soto
Gael Chávez-Alonso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356991

3,982 views
1 citation

Original Research

Published on 10 Jun 2024

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

in Renal Pharmacology

Jian-Chun Li
Shi-Tao Huang
Fei Feng
Lin-Jun Wang
Ting-Ting Chen
Min Li
Li-Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389354

3,185 views
1 citation

Review

Published on 07 Jun 2024

Targeting pyruvate kinase M2 for the treatment of kidney disease

in Renal Pharmacology

Dan-Qian Chen
Jin Han
Hui Liu
Kai Feng
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376252

4,680 views
3 citations

Original Research

Published on 07 Jun 2024

Myricitrin inhibited ferritinophagy-mediated ferroptosis in cisplatin-induced human renal tubular epithelial cell injury

in Renal Pharmacology

Jiawen Lin
Yangyang Zhang
Hui Guan
Shuping Li
Yuan Sui
Ling Hong
Zhihua Zheng
Mingcheng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372094

3,164 views
5 citations

Systematic Review

Published on 30 May 2024

Pooled-analysis of tadalafil and tamsulosin for ureteral calculi

in Renal Pharmacology

Fengze Sun
Hongquan Liu
Gang Wu
Ming Liu
Shangjing Liu
Lin Wang
Qingsong Zou
Yuanshan Cui
Jitao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1351312

2,688 views

Original Research

Published on 30 May 2024

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis

in Renal Pharmacology

Emiko Otsuka
Mineaki Kitamura
Satoshi Funakoshi
Hiroshi Mukae
Tomoya Nishino

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362242

2,785 views
4 citations

Original Research

Published on 23 May 2024

Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease

in Renal Pharmacology

Philip W. Brownjohn
Azedine Zoufir
Daniel J. O’Donovan
Saatviga Sudhahar
Alexander Syme
Rosemary Huckvale
John R. Porter
Hester Bange
Jane Brennan
Neil T. Thompson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397864

3,988 views
2 citations

Original Research

Published on 23 May 2024

Mortality prediction and influencing factors for intensive care unit patients with acute tubular necrosis: random survival forest and cox regression analysis

in Renal Pharmacology

Jinping Zeng
Min Zhang
Jiaolan Du
Junde Han
Qin Song
Ting Duan
Jun Yang
Yinyin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361923

1,406 views

Original Research

Published on 22 May 2024

Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization study

in Renal Pharmacology

Xin Lv
Yan Shang
Yong Ning
Weimin Yu
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399881

5,521 views
6 citations